Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Return on Equity (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Return on Equity for 7 consecutive years, with 0.27% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 23.0% to 0.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27% through Dec 2025, down 23.0% year-over-year, with the annual reading at 0.25% for FY2025, 21.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.27% at Fulcrum Therapeutics, up from 0.34% in the prior quarter.
  • The five-year high for Return on Equity was 0.0% in Q1 2025, with the low at 0.62% in Q1 2021.
  • Average Return on Equity over 5 years is 0.37%, with a median of 0.38% recorded in 2023.
  • Peak annual rise in Return on Equity hit 44bps in 2025, while the deepest fall reached -28bps in 2025.
  • Over 5 years, Return on Equity stood at 0.37% in 2021, then plummeted by -43bps to 0.52% in 2022, then rose by 24bps to 0.4% in 2023, then soared by 90bps to 0.04% in 2024, then crashed by -604bps to 0.27% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.27%, 0.34%, and 0.33% for Q4 2025, Q3 2025, and Q2 2025 respectively.